Sort by
Refine Your Search
-
Country
-
Employer
-
Field
-
The position is hybrid, but primarily laboratory-based. A strong experimental profile is essential. We are looking for a candidate who: Holds a PhD in molecular biology, biochemistry, pharmacology, protein
-
Researcher (R2) Positions PhD Positions Application Deadline 15 Feb 2026 - 23:45 (Europe/Dublin) Country Ireland Type of Contract Temporary Job Status Full-time Hours Per Week 39 Is the job funded through
-
approach encompassing protein biochemistry, proteomics, molecular genetics, genome editing, and cell biology. Primarily, these investigations will be conducted in Arabidopsis and Tobacco, with a subsequent
-
.•Recombinant protein and antigen expression for vaccine and diagnostic development.•Development and optimization of advanced immunological assays (ADE/ADCC) and yeast-surface display for antibody-antigen
-
Vulnerabilities This project aims to explore the dynamic nature of the human replisome, with a focus on replisome protein architecture, replisome speed control, and replication stress responses in cancer cells. By
-
to explore the dynamic nature of the human replisome, with a focus on replisome protein architecture, replisome speed control, and replication stress responses in cancer cells. By combining CRISPR-based
-
existing genetic tools and constructs Work with surface-displayed and soluble carbonic anhydrases Perform biochemical and functional characterisation of carbonic anhydrase variants Apply established
-
(B): Experience in protein engineering/ directed evolution, biocatalysis and/or enzymology. Area (C ): organic chemistry, catalysis, methodology development. The ideal candidates should have a PhD
-
University of North Carolina at Chapel Hill | Chapel Hill, North Carolina | United States | 1 day ago
, CAR-T therapies, computational protein modeling and design, directed evolution (Yeast display, phage display) is preferred. Special Physical/Mental Requirements Special Instructions For information